glp 1 agonist therapy Frontiers Doctyn Academy | GLP-1 receptor

Approved for chronic weight management in adults with obesity or weight-related conditions

Pharmacotherapy of obesity: an update on the available medications and drugs under investigation

Enter semaglutide, one of a class of medicines the GLP-1-receptor agonists that imitate GLP-1, helping the body lower glucose (in the case of people with diabetes) and, researchers suspect, curb appetite (in the case of people living with obesity who may also have diabetes)

Appetite suppression becomes noticeable within 2-3 days of the first injection, but significant weight loss takes weeks to months

J Clin Hypertens (Greenwich)